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Ambros and Ruvkun groups were the first who discovered
microRNA(miRNA), lin-4, in 1993. During the time, lots of studies
regarding to miRNA, its biogenesis, circulation, mechanisms and
involvement in human disease were done. Today, miRNA is known as a
small non-coding RNA molecule that functions in RNA silencing and
post-transcriptional regulation of gene expression.
miRNAs errors and their defective interference in regulation of gene
expression, as well as their long distance action can be correlated with
the development and malignization of ovarian cancer, affecting women’s
health and recording the highest mortality rate among reproductive
system tumors.













HINARI, PubMed and Cochrane Library 
databases were analysed. 
High levels of miR-200, miR-199a were
identified, while, on the other hand, miR-140,
miR-145, miR-15, responsible of tumor
supression, apoptosis and cell proliferation
regulation, were low expressed.
A dramatic increase of miR-205 in the late
stages of ovarian cancer was observed. Its
function is to inhibit transcription factor 21
(TCF21) expression and its inhibitory effect on
cell invasion.
Reestablishing the expression of let-7 can
significantly reduce the growth of tumors, while
inhibiting the expresion of proto-oncogenes
proteins RAS, HMGA 2, c-Myc, cdk 6.
A
miRNA is important in regulating
gene expression in cells. The
modifications in miRNAs encoding
genes are responsible of the
development of ovarian tumors.
Serum miRNA can be used as a
marker for early diagnosis of
ovarian cancer.
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